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Abstract
Background: Reusable surface disinfectant tissue dispensers are used in hospitals in many countries because they
allow immediate access to pre-soaked tissues for targeted surface decontamination. On the other hand disinfectant
solutions with some active ingredients may get contaminated and cause outbreaks. We determined the frequency
of contaminated surface disinfectant solutions in reusable dispensers and the ability of isolates to multiply in
different formulations.
Methods: Reusable tissue dispensers with different surface disinfectants were randomly collected from healthcare
facilities. Solutions were investigated for bacterial contamination. The efficacy of two surface disinfectants was
determined in suspension tests against two isolated species directly from a contaminated solution or after 5
passages without selection pressure in triplicate. Freshly prepared use solutions were contaminated to determine
survival of isolates.
Results: 66 dispensers containing disinfectant solutions with surface-active ingredients were collected in 15
healthcare facilities. 28 dispensers from nine healthcare facilities were contaminated with approximately 107 cells
per mL of Achromobacter species 3 (9 hospitals), Achromobacter xylosoxidans or Serratia marcescens (1 hospital each).
In none of the hospitals dispenser processing had been adequately performed. Isolates regained susceptibility to
the disinfectants after five passages without selection pressure but were still able to multiply in different
formulations from different manufacturers at room temperature within 7 days.
Conclusions: Neglecting adequate processing of surface disinfectant dispensers has contributed to frequent and
heavy contamination of use-solutions based on surface active ingredients. Tissue dispenser processing should be
taken seriously in clinical practice.
Keywords: Surface disinfection, Reusable dispenser, Surface-active biocidal ingredients, Bacterial contamination,
Achromobacter spp, Adaptation, Biofilm
Background
The emergence of multi-resistant Gram-negative bacteria
in healthcare associated infections has led to an increased
awareness for prevention of transmission [1], e.g. by hand
disinfection or targeted surface disinfection [2]. Especially
surfaces in the immediate proximity of patients and those
with frequent hand contacts should be wiped regularly
with a surface disinfectant which may contain quaternary
ammonium compounds (QAC), amines, glucoprotamin or
amphotensides (all summarized as “surface-active ingredi-
ents”), aldehydes, alcohols or oxygen-releasing compounds
[3]. In recent years reusable tissue dispensers for surface
disinfection became more popular with the aim to facili-
tate targeted surface disinfection in areas with frequent
hand contacts or in high risk areas such as intensive care
units [4]. They are also recommended as one of many
measures to control outbreaks, e.g. caused by Serratia
marcescens in neonatology units [5]. Manufacturers of
dispensers usually recommended how to process them
before refilling with use solutions and tissue roles but
compliance with the recommendation in clinical prac-
tice is unknown. We were informed in connection with
an outbreak by Serratia spp. in a neonatology unit that
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“Pseudomonas species” at approximately 107 cells per mL
was detected in a single dispenser containing a surface
disinfectant solution based on the QAC benzalkonium
chloride (BAC) (Exner M.; personal communication).
That is why we determined the frequency of contaminated
surface disinfectant solutions in reusable dispensers, the
ability of isolates to multiply in different formulations and
their ability to form biofilms.
Methods
Determination of the dispenser contamination rate in
healthcare facilities
Seventy dispensers or solutions from dispensers were
collected randomly from various healthcare facilities as
well as information on the date of last refill, type and
date of last routine dispenser processing and type of
disinfectant dosage (e.g. manual dosing or use of a per-
ipheral disinfectant dosage apparatus). The focus was on
surface disinfectant solutions based only on surface-active
ingredients such as quaternary ammonium compounds
(QAC), amphotensides, amines or glucoprotamin, but
other preparations based on alcohols or aldehydes in
combination with QAC were also collected. Preferably
solutions in a concentration of 0.5% which are de-
scribed as effective within one hour and which are rec-
ommended in risk areas (e.g. intensive care units and
operating theaters) [6] and on surfaces with frequent
hand contacts were collected. Each solution was tested
for bacterial contamination by serial dilution in casein
peptone soymeal peptone broth containing neutralizing
agents (0.1% histidin, 0.1% cysteine, 0.3% lecithin, 3%
Tween 80). The combination of neutralizers was validated
and effective for all tested products. Aliquots of one mL
were spread on casein peptone soymeal peptone agar and
incubated for 72 h. Colonies were counted to calculate
the number of colony-forming units (CFU) per mL.
Whenever a high bacterial contamination of the solu-
tion was found the species was identified by MALDI
mass spectrometry (Bruker Daltonik GmbH, Bremen,
Germany). A pulsed field gel electrophoresis (PFGE) of
Achromobacter species 3 isolates was performed using
Xba I as restriction enzyme [7].
Survival of isolates in disinfectant solutions over 28 days
In order to find out if isolates are capable to multiply in
different types of disinfectant solutions, we contaminated
3 dispensers per product using an aliquot of 25 mL of the
bacterial suspension with a cell number adjusted to ap-
proximately 107 cells per mL. Three days later tissue roles
were inserted (X-Wipes; Bode Chemie GmbH, Hamburg,
Germany) and use solutions (0.5%) of four surface disin-
fectants added (Mikrobac forte and Kohrsolin FF, Bode
Chemie GmbH, Hamburg, Germany; Terralin protect,
Schülke & Mayr GmbH, Norderstedt, Germany; Incidin
plus, Ecolab Deutschland GmbH, Düsseldorf, Germany).
Three different types of contaminants were used: the
adapted isolate Achromobacter species 3 directly from a
contaminated surface disinfectant solution, the same
isolate passaged five times on casein peptone soymeal
peptone agar to allow loss of adaptation, and finally the
closely related species Achromobacter xylosoxidans as
ATCC strain 27061. A dispenser was filled with 2.5 L of
disinfectant solution. Dispensers with the disinfectant
solution and a role of tissues were left at room temperature
for 28 days. A sample of the disinfectant solution was taken
on days seven, 14, 21 and 28. Serial dilution was performed
in casein peptone soymeal peptone broth containing
neutralizing agents (0.1% histidin, 0.1% cysteine, 0.3%
lecithin, 3% Tween 80). The number of colony-forming
units (CFU) per mL was determined.
Adaptation of isolates to surface disinfectant
In order to find out if the isolates detected in surface
disinfectant solutions were adapted to the formulation,
the bactericidal activity of Mikrobac forte and Incidin
plus (1% for 30 min, 0.5% for one h, 0.25% for four h)
was determined according to EN 13727 [8] in triplicate
under dirty conditions against the species that were de-
tected in the solutions with the same strain at passage
zero directly from the contaminated disinfectant solution
and passage five (five passages on casein peptone soymeal
peptone agar at 37°C without selection pressure). Corre-
sponding ATCC strains were also tested. An increase of
susceptibility of the isolates from passage zero to passage
five was regarded as evidence for adaptation.
Biofilm formation in disinfectant solution over 23 days
Biofilm formation was measured in triplicate with one
strain of Achromobacter species 3 and one strain of
Serratia marcescens as described by O’Toole et al. [9].
Both strains were used in the adapted (passage 0) and
de-adapted cell stage (passage 5). A microtiter plate based
on polypropylene was used (Thermo Fisher Scientific,
Langenselbold, Germany) which is the compound most
reusable dispenser for surface disinfection tissues are
made off. The contamination fluid for both species was
prepared in disinfectant solution of products based on
surface-active ingredients (Mikrobac forte, Bode Chemie
GmbH, Hamburg, Germany; Terralin protect, Schülke &
Mayr GmbH, Norderstedt, Germany; Incidin plus, Ecolab
Deutschland GmbH, Düsseldorf, Germany), sterile physio-
logical sodium chloride solution (negative control) and
tryptic soy broth (TSB; positive control) resulting in a cell
concentration of approximately 107 CFU/mL. Microtiter
plates were filled with 300 μL of contamination fluid per
well and left for 3 days under a work bench for sterile
goods. Each well was then filled with 300 μL of disinfect-
ant solution (0.5%), physiological sodium chloride solution
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or tryptic soy broth. Microtiter plates were left at room
temperature. Biofilm formation was quantified after 2, 3,
4, 5 and 24 h and after 2, 8, 10 and 23 days. At each time
point plates were dumped out in order to remove any
liquid, gently submerged in a tub of water, stained with
300 μL of 2% crystal violet for 15 min, submerged again in
a tub of water, and finally filled with 300 μL of 30% acetic
acid to solubilize crystal violet. After 15 minutes at room
temperature absorbance was quantified at 550 nm using
30% acetic acid in water as the blank. Absorbance in the
negative control was regarded as baseline. The OD550 nm
for non-specific background staining of each disinfectant
solution or TSB medium was subtracted from raw values
for of each disinfectant solution or TSB medium. Biofilm
formation in the disinfectant solution and the positive
control was calculated as the ratio between their mean
OD550 nm and the mean OD550 nm of the negative control
expressed as a relative change.
Results
Dispensers or solutions from dispensers were obtained
from 15 healthcare facilities (13 hospitals, two medical
practices) in four regions of Germany. 66 of them con-
tained surface disinfectants based only on surface-active
ingredients (51 of them in a concentration of 0.5%, 11 in
a concentration of 0.25% and four dispensers with an
unknown disinfectant concentration). Four dispensers
also contained aldehyde (solution of 0.5%) or alcohol
(ready to use). The mean time between the last refill and
the collection of the dispenser was 17.7 days (minimum:
three days, maximum 58 days). Processing of the dis-
pensers as recommended by the manufacturer was not
performed in any of the participating healthcare facil-
ities. A heavy contamination with 106 to 107 cells per
mL was found in 28 of the solutions with surface-active
ingredients (42.4%) whereas the disinfectants containing
also aldehydes or alcohol did not reveal any relevant
contamination. Whenever a contamination was detected
the healthcare facility was immediately informed to allow
instant removal of other dispensers. Achromobacter species
3 was identified in dispensers of all nine healthcare
facilities with contaminated solutions, from one of these
Serratia marcescens could be isolated as well. Achromo-
bacter xylosoxidans was cultivated in one dispenser. Eight
isolates of Achromobacter species 3 were available for
PFGE and represented seven different strains, two isolates
from one hospital were genotypically identical.
At both concentrations Incidin plus showed insuffi-
cient bactericidal activity with a mean log10-reduction
between 0.00 and 0.09 against both dispenser isolate spe-
cies from passage 0 (Table 1). Mikrobac forte revealed
similar results against one dispenser isolate species
(mean log10-reduction between 0.00 and 0.08) but was
found much more effective against another (mean log10-
Table 1 Mean log10-reduction of two surface disinfectants against un-passaged and passaged isolates from
contaminated use-solutions
Bacterial species (origin) Surface disinfectant, concentration (exposure time) Passage 0 Passage 5
Achromobacter species 3 (dispenser isolate) Mikrobac forte 1% (0.5 h) ≥ 6.04 ≥ 6.80
Mikrobac forte 0.5% (1 h) 4.61 ± 0.17 ≥ 6.76
Mikrobac forte 0.25% (4 h) 2.39 ± 0.13 4.43 ± 0.09
Serratia marcescens (dispenser isolate) Mikrobac forte 1% (0.5 h) 0.08 ± 0.04* 6.82 ± 0.62
Mikrobac forte 0.5% (1 h) 0.08 ± 0.06* 2.38 ± 0.03
Mikrobac forte 0.25% (4 h) 0.00 ± 0.02* < 1.68
Achromobacter xylosoxidans (ATCC 27061) Mikrobac forte 1% (0.5 h) ≥ 7.35 n.a.
Mikrobac forte 0.5% (1 h) 6.29 ± 1.02 n.a.
Mikrobac forte 0.25% (4 h) 6.28 ± 0.16 n.a.
Achromobacter species 3 (dispenser isolate) Incidin plus 1% (0.5 h) 0.03 ± 0.06 4.59 ± 0.06
Incidin plus 0.5% (1 h) 0.06 ± 0.04 2.37 ± 0.01
Incidin plus 0.25% (4 h) 0.09 ± 0.06 < 2.27
Achromobacter xylosoxidans (dispenser isolate) Incidin plus 1% (0.5 h) 0.05 ± 0.03 ≥ 7.02
Incidin plus 0.5% (1 h) 0.02 ± 0.01 5.42 ± 0.13
Incidin plus 0.25% (4 h) 0.00 ± 0.04 4.58 ± 0.07
Achromobacter xylosoxidans (ATCC 27061) Incidin plus 1% (0.5 h) ≥ 7.18 n.a.
Incidin plus 0.5% (1 h) ≥ 7.18 n.a.
Incidin plus 0.25% (4 h) ≥ 7.19 n.a.
Achromobacter species 3, Achromobacter xylosoxidans and Serratia marcescens isolated from passages 0 and 5; n = 3; dirty conditions; *passage 1 was used due to
the co-contamination with Achromobacter species 3; n.a = not applicable.
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reduction between 2.39 and 6.04). After five passages of
the same isolates the efficacy increased mostly. Against
ATCC strains both surface disinfectants were highly
effective.
Achromobacter species 3 was able to multiply at room
temperature in three different surface disinfectants based
only on surface-active ingredients (all at 0.5%; Table 2).
Multiplication was found within one to four weeks up to
a cell number of 107 per mL regardless of using adapted
or passaged cells. No multiplication of Achromobacter
species 3 was found in a surface disinfectant containing
in addition aldehyde (solution of 0.5%), or alcohol (ready
to use; data not shown). Achromobacter xylosoxidans
ATCC 27061, however, was not detected over four weeks
Table 2 Number of CFU per mL of dispenser isolates transferred in fresh surface disinfectant solution at room
temperature
Product at a dilution
to be effective in
60 minutes
Active ingredient(s) of undiluted product;
concentration (w/w)
Type of cells Dispenser CFU/mL
Day 7 Day 14 Day 21 Day 28
Mikrobac forte (0.5%) Benzyl-C12-18-alkyldimethylammoniumchloride (19.9%),
N-(3-Aminopropyl)-N-dodecylpropan-1,3-diamin (5%)
Adapted cells 1 106 107 n.a. n.a.
2 106 107 n.a. n.a.
3 106 107 n.a. n.a.
De-adapted cells 1 107 107 n.a. n.a.
2 107 107 n.a. n.a.
3 107 107 n.a. n.a.
ATCC 27061 1 0 0 0 0
2 0 0 0 0
3 0 0 0 0
Kohrsolin FF (0.5%) Glutaral (5%),
Benzyl-C12-18-alkyldimethylammoniumchloride (3%),
Didecyldimethylammoniumchlorid (3%)
Adapted cells 1 0 0 0 0
2 0 0 0 0
3 0 0 0 0
De-adapted cells 1 0 0 0 0
2 0 0 0 0
3 0 0 0 0
Terralin protect (0.5%) Quaternary ammonium compound,
Benzyl-C12-16-alkyl-dimethylchloride (22%),
2-Phenoxyethanol (17%), Aminoalkylglycine (0.9%)
Adapted cells 1 60 107 n.a. n.a.
2 45 107 n.a. n.a.
3 35 107 n.a. n.a.
De-adapted cells 1 107 107 n.a. n.a.
2 107 107 n.a. n.a.
3 107 107 n.a. n.a.
ATCC 27061 1 0 0 0 0
2 0 0 0 0
3 0 0 0 0
Incidin plus (0.5%) Glucoprotamin (26%) Adapted cells 1 103 107 n.a. n.a.
2 107 107 n.a. n.a.
3 103 107 n.a. n.a.
De-adapted cells 1 107 107 n.a. n.a.
2 107 107 n.a. n.a.
3 107 107 n.a. n.a.
ATCC 27061 1 0 0 0 0
2 0 0 0 0
3 0 0 0 0
Achromobacter species 3 (passage 0 as adapted cells, and passage 5 as de-adapted cells) or Alcaligenes xylosoxidans ATCC 27061 after up to 28 days in a freshly
prepared disinfectant solution (2.5 l) with tissues, prepared in a fresh dispenser which was first contaminated with 25 ml of inoculum (approximately 107 CFU
per mL).
n.a.: not available.
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in any of the disinfectant solutions based on surface-active
ingredients.
In polypropylene microtiter plates biofilm formation
was found within a few hours in all three surface disinfect-
ant solutions contaminated with Achromobacter species
3 or Serratia marcescens. After 23 days Achromobacter
species 3 formed up to five times more biofilm in all
three surface disinfectant solutions in both the adapted
and de-adapted cell stage (Figure 1). Similar results were
found with Serratia marcescens (Figure 2). Both isolates
were capable only in the positive control to produce large
amounts of biofilm (up to 145 times) with the trend to
more biofilm formation formed by the de-adapted cells.
No major difference was found between the three surface
disinfectant solutions.
Discussion
The frequency of bacterial contamination found in solu-
tions for surface disinfection based on surface active ingre-
dients was surprisingly high with an overall rate of 42%.
To the best of our knowledge none of the collected con-
taminated dispensers was identified as the source or asso-
ciated with a nosocomial infection in the participating
health care facilities although we can exclude that single
transmission may have occurred but was not noted or
reported. In most cases Achromobacter species 3 were
detected but Serratia marcescens and Achromobacter
xylosoxidans could be isolated as well. Achromobacter
spp. is known to cause only rarely nosocomial infections
such as septicemia, pneumonia or peritonitis [10]. Espe-
cially critically ill patients e.g. from neonatology units
or with immunosuppression are at risk [11]. The main
cause of surface disinfectant contamination seems to be
the inappropriate processing of reusable tissue dispensers.
In one hospital, the dispensers were only rinsed with tap
water. In another hospital the last tissue was used for a
brief wipe of the dispenser’s inner surface. That is why it is
essential that effective processing is not only recom-
mended by the manufacturer but also correctly carried
out by the staff of health care facilities.
Inappropriate processing has probably supported the
bacterial cells to adapt to the formulations as shown
with Achromobacter species 3, and to produce biofilm.
Development of tolerance in the presence of BAC has
been shown before [12]. This tolerance, however, may
get lost again [12]. In our isolates Achromobacter species
3 and Serratia marcescens we found the same pattern in-
dicating that the reduced susceptibility is most likely ex-
plained by a transient adaption to BAC or glucoprotamin.
Adaption to BAC has a potentially harmful consequence.
It may substantially enhance biofilm production by non-
BAC-resistant cells in the post-adaption period as a re-
sponse to the antimicrobial stress [13]. Originally resistant
isolates probably experienced lesser stress during adapta-
tion, and hence displayed only marginal increase in biofilm
formation [13]. Isolates with a resistance to BAC are also
commonly resistant to different types of antibiotics [14,15]
or to other types of surfactants such as benzethonium
chloride or alkyldiaminoethylglycine [16]. Assuming that
most isolates in clinical practice are not originally resist-
ant, one should expect a rather high biofilm forming cap-























































































Figure 1 Biofilm formation of Achromobacter species 3 in surface disinfectant solutions in polypropylen microtiter plates. Cells were
used as passage 0 (adapted) and passage 5 (de-adapted), surface disinfectants were prepared at 0.5%, TSB was the positive control; mean and
stdev of three experiments.
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multiplying in BAC use solution. This aspect makes a
thorough cleaning of dispensers even more important not
only for dispensers used over 28 days but also for dis-
pensers used every day with a freshly prepared disinfectant
solution [17].
Multiplication of Achromobacter species 3 was found at
room temperature which is not its optimum temperature
for growth [18]. This could be demonstrated only in
surface disinfectant solution (0.5%) but not in water in-
dicating that at least these formulations seem to provide
a “friendly environment” for bacterial growth. Different
Gram-negative species are known to show different sus-
ceptibilities to BAC [19]. Solutions with specific active
agents may get contaminated and thereby contribute to
the transmission of pathogens – at the worst resulting
in an outbreak situation [20,21]. Most outbreaks were
reported with solutions based on benzalkonium chloride
(BAC) which is the most commonly used QAC in surface
disinfection. Whenever a contamination with BAC was de-
tected, it was either a Gram-negative bacterial species (e.g.
Pseudomonas species, Serratia marcescens, Burkholderia
cepacia or Enterobacter aerogenes) or in two cases a myco-
bacterial species [20]. Multiplication of Serratia marcescens
up to 107 cells per mL has been described before in the
presence of BAC or in a disinfectant based on QAC
[22,23]. The reason for this, however, is not fully under-
stood, yet, some mechanisms have been elucidated. Re-
peated exposure of Serratia marcescens to a QAC has
been described to cause the emergence of mutants re-
sistant not only to multiple species of biocides but also
to structurally and functionally diverse antibiotics [24].
Exposure of the mutants to the QAC results in overex-
pression of an efflux pump, SdeAB [24]. Similar obser-
vations were made with glucoprotamin. Pancer et al.
describe that the efficacy of glucoprotamin is reduced
when microorganisms are presented in biofilm [25].
The lowest effectiveness on biofilm forming bacteria
showed the disinfectant with glucoprotamine compared
to formulations based on sodium dichloroisocyanurate
or potassium persulfate [25]. Alcaligenes xylosoxidans
has been described to use triclosan as a carbon source
resulting in a reduction of the triclosan concentration
over time [26]. In our samples from hospitals, however,
we did not find a reduced level of BAC indicating that
BAC is not metabolized in a relevant amount [27,28].
It becomes quite evident that the current clinical prac-
tice of dispenser processing with a “quick and dirty” ap-
proach is not suitable to ensure safe surface disinfectant
solutions with formulations based on surface-active ingre-
dients over 28 days, in some samples not even over three
days. First data indicate that processing of contaminated
dispensers from clinical practice is not as easy as many
practitioners think if re-contamination of the disinfectant
solution shall be prevented for a period of up to 28 days
[29]. This finding raises serious doubts on the efficacy
of manufacturer’s dispenser processing recommenda-
tions if not supported by sound scientific evidence.
That is why evidence-based protocols for dispenser pro-
cessing should be available as soon as possible. Some
examples are available already, e.g. for effective auto-
matic (professional washer disinfector; process for at
least 5 minutes at 55°C – 60°C) and manual processes
(thorough rinse with hot water, drying, thorough disinfec-
tion with alcohol-based surface disinfectant, allow to dry)
[29]. These processing protocols should be accompanied
with excellent staff training and stipulation of a HACCP-
like quality assurance system [4] since potential errors by
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Figure 2 Biofilm formation of Serratia marcescens in surface disinfectant solutions in polypropylen microtiter plates. Cells were used as
passage 0 (adapted) and passage 5 (de-adapted), surface disinfectants were prepared at 0.5%, TSB was the positive control; mean and stdev of
three experiments.
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does not change in that respect we have to be aware that
outbreaks propagated by contaminated surface disinfect-
ant solutions based on BAC or glucoprotamine as a point
source might be reported soon. Additional concern may
arise because Achromobacter xylosoxidans is apparently
a reservoir of horizontal genetic transfer elements com-
monly involved in spreading antibiotic resistance [30].
Inappropriately processed dispensers will allow this patho-
gen to persist in the environment of healthcare facilities
with all possible implications.
Conclusions
Disinfectant solutions based on surface-active ingredients
from poorly processed tissue dispensers are frequently con-
taminated with adapted biofilm-forming Gram-negative
bacteria. Effective processing of tissue dispensers is es-
sential to eliminate them as a possible source of patho-
gen transmission and consecutive infections especially if
disinfectants based on QAC, amines or glucoprotamin
are used.
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